Driven by research, grounded in care.
Founded in Perth in 2012, TrialsWest began with a focus on respiratory research before expanding across a broad range of therapeutic areas. Today we partner with some of the world’s leading pharmaceutical companies, including GSK, AstraZeneca, Novartis, Merck, Sanofi, Boehringer Ingelheim, Bayer and Biogen, to conduct Phase II to IV clinical trials across Perth, Australia.
Our Team
Dr Helen Pavitt
Head of Clinical Trials
BSc Hons, PhD
Since 2004 Helen has been involved in the conduct of over 50 clinical trials (phase Ib, II, III, IV and pre-clinical) in the following therapeutic areas: respiratory, gastroenterology, hepatology, haematology, ENT, nephrology and vaccines. Helen was previously the Clinical Manager at Resonance Health and the Manager of the Clinical Trials Unit at the Lung Institute of Western Australia.
Michelle Davies
Clinical Trials Manager
BSc (Nursing)
Michelle is a registered nurse and has been managing clinical trials for over 15 years. She is experienced in conducting Phase Ib to Phase IV clinical trials in the following indications: respiratory, ENT, vaccines and nephrology. Michelle was previously the Manager of the Clinical Trials Unit at the Lung Institute of Western Australia.
Prof. Peter Bremner
Medical Director
MBChB, FRACP, MD
Professor Bremner is a respiratory physician and has been involved in more than 70 clinical trials over the past 25 years.
This experience has included involvement in phase 1b, II, III and IV clinical trials as both the Principal Investigator and Co-Investigator.